

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 9.69908696 |
| 2 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 8.93874040 |
| 3 | UMP metabolic process (GO:0046049) | 8.93874040 |
| 4 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 8.93874040 |
| 5 | UMP biosynthetic process (GO:0006222) | 8.93874040 |
| 6 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 8.59375093 |
| 7 | regulation of T cell chemotaxis (GO:0010819) | 8.33688913 |
| 8 | positive regulation of T cell chemotaxis (GO:0010820) | 8.33688913 |
| 9 | * regulation of immunoglobulin secretion (GO:0051023) | 8.20570034 |
| 10 | * regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 7.91716580 |
| 11 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 7.73752331 |
| 12 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 7.48355043 |
| 13 | regulation of podosome assembly (GO:0071801) | 7.21793086 |
| 14 | regulation of memory T cell differentiation (GO:0043380) | 7.13598900 |
| 15 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.92294007 |
| 16 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 6.89996102 |
| 17 | positive regulation of humoral immune response (GO:0002922) | 6.87388700 |
| 18 | regulation of vitamin metabolic process (GO:0030656) | 6.17413831 |
| 19 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 6.15305552 |
| 20 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 6.13788658 |
| 21 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 6.13788658 |
| 22 | pyrimidine ribonucleoside biosynthetic process (GO:0046132) | 6.12055951 |
| 23 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 6.10142011 |
| 24 | tyrosine phosphorylation of STAT protein (GO:0007260) | 6.05988514 |
| 25 | * positive regulation of B cell mediated immunity (GO:0002714) | 6.00194326 |
| 26 | * positive regulation of immunoglobulin mediated immune response (GO:0002891) | 6.00194326 |
| 27 | regulation of lymphocyte chemotaxis (GO:1901623) | 5.86861634 |
| 28 | pyrimidine ribonucleotide biosynthetic process (GO:0009220) | 5.85136882 |
| 29 | myeloid dendritic cell differentiation (GO:0043011) | 5.83129157 |
| 30 | polarized epithelial cell differentiation (GO:0030859) | 5.79578625 |
| 31 | response to gravity (GO:0009629) | 5.75400128 |
| 32 | cellular response to nicotine (GO:0071316) | 5.74699950 |
| 33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.65592631 |
| 34 | cellular protein complex localization (GO:0034629) | 5.60856600 |
| 35 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 5.59990809 |
| 36 | regulation of chronic inflammatory response (GO:0002676) | 5.29594411 |
| 37 | pyrimidine ribonucleotide metabolic process (GO:0009218) | 5.25083407 |
| 38 | signal peptide processing (GO:0006465) | 5.24965361 |
| 39 | positive regulation of T cell cytokine production (GO:0002726) | 5.22030058 |
| 40 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.18928260 |
| 41 | * regulation of isotype switching to IgG isotypes (GO:0048302) | 5.13314909 |
| 42 | regulation of gamma-delta T cell activation (GO:0046643) | 5.07245567 |
| 43 | myeloid dendritic cell activation (GO:0001773) | 5.03538894 |
| 44 | * regulation of immunoglobulin production (GO:0002637) | 4.98039105 |
| 45 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 4.85736283 |
| 46 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 4.75035281 |
| 47 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 4.68351967 |
| 48 | GTP biosynthetic process (GO:0006183) | 4.66770678 |
| 49 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.66057169 |
| 50 | ribosome biogenesis (GO:0042254) | 4.63783429 |
| 51 | pyrimidine nucleotide biosynthetic process (GO:0006221) | 4.60943970 |
| 52 | * regulation of immunoglobulin mediated immune response (GO:0002889) | 4.57235262 |
| 53 | activated T cell proliferation (GO:0050798) | 4.57228377 |
| 54 | negative T cell selection (GO:0043383) | 4.50836605 |
| 55 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.47455044 |
| 56 | interferon-gamma production (GO:0032609) | 4.46560094 |
| 57 | negative regulation of T cell mediated immunity (GO:0002710) | 4.44506999 |
| 58 | behavioral response to nicotine (GO:0035095) | 4.44155449 |
| 59 | * positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531) | 4.43599812 |
| 60 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 4.41501839 |
| 61 | * regulation of B cell mediated immunity (GO:0002712) | 4.40827196 |
| 62 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.39752607 |
| 63 | * positive regulation of isotype switching (GO:0045830) | 4.39114198 |
| 64 | regulation of fever generation (GO:0031620) | 4.36922547 |
| 65 | positive regulation of heat generation (GO:0031652) | 4.29174175 |
| 66 | pyrimidine nucleoside biosynthetic process (GO:0046134) | 4.28889962 |
| 67 | T cell proliferation (GO:0042098) | 4.21937037 |
| 68 | negative thymic T cell selection (GO:0045060) | 4.20294575 |
| 69 | positive regulation of defense response to virus by host (GO:0002230) | 4.19554480 |
| 70 | positive thymic T cell selection (GO:0045059) | 4.18873378 |
| 71 | * positive regulation of immunoglobulin production (GO:0002639) | 4.16907241 |
| 72 | UTP biosynthetic process (GO:0006228) | 4.12634515 |
| 73 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.09394844 |
| 74 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 4.04416902 |
| 75 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.03193268 |
| 76 | T cell homeostasis (GO:0043029) | 3.98175362 |
| 77 | positive regulation of astrocyte differentiation (GO:0048711) | 3.98108665 |
| 78 | positive regulation of T cell migration (GO:2000406) | 3.96593648 |
| 79 | regulation of lymphocyte migration (GO:2000401) | 3.95299196 |
| 80 | positive T cell selection (GO:0043368) | 3.94727026 |
| 81 | response to interleukin-15 (GO:0070672) | 3.92674891 |
| 82 | CTP biosynthetic process (GO:0006241) | 3.92485646 |
| 83 | CTP metabolic process (GO:0046036) | 3.92485646 |
| 84 | embryonic hemopoiesis (GO:0035162) | 3.91825267 |
| 85 | positive regulation of immune response to tumor cell (GO:0002839) | 3.89637564 |
| 86 | regulation of immune response to tumor cell (GO:0002837) | 3.89637564 |
| 87 | regulation of response to tumor cell (GO:0002834) | 3.89637564 |
| 88 | positive regulation of response to tumor cell (GO:0002836) | 3.89637564 |
| 89 | * positive regulation of interleukin-17 production (GO:0032740) | 3.88072261 |
| 90 | * regulation of tyrosine phosphorylation of STAT protein (GO:0042509) | 3.86373947 |
| 91 | positive regulation of lymphocyte migration (GO:2000403) | 3.85294354 |
| 92 | protein complex localization (GO:0031503) | 3.84409102 |
| 93 | positive regulation of cell fate commitment (GO:0010455) | 3.76845157 |
| 94 | * positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.71452374 |
| 95 | amine catabolic process (GO:0009310) | 3.71178179 |
| 96 | cellular biogenic amine catabolic process (GO:0042402) | 3.71178179 |
| 97 | * regulation of JAK-STAT cascade (GO:0046425) | 3.69546120 |
| 98 | folic acid transport (GO:0015884) | 3.68107064 |
| 99 | * positive regulation of JAK-STAT cascade (GO:0046427) | 3.67579826 |
| 100 | UTP metabolic process (GO:0046051) | 3.65023817 |
| 101 | cellular response to interleukin-15 (GO:0071350) | 3.63917650 |
| 102 | polyamine metabolic process (GO:0006595) | 3.57688367 |
| 103 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.57514253 |
| 104 | positive regulation of cell killing (GO:0031343) | 3.57128796 |
| 105 | regulation of activation of Janus kinase activity (GO:0010533) | 3.56475364 |
| 106 | * positive regulation of DNA recombination (GO:0045911) | 3.56124719 |
| 107 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.55602022 |
| 108 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.53348510 |
| 109 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.53348510 |
| 110 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.53301767 |
| 111 | Peyers patch development (GO:0048541) | 3.53301767 |
| 112 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.52805601 |
| 113 | pyrimidine nucleotide metabolic process (GO:0006220) | 3.52756894 |
| 114 | negative regulation of receptor activity (GO:2000272) | 3.51206120 |
| 115 | positive regulation of interleukin-12 production (GO:0032735) | 3.51188677 |
| 116 | positive regulation of organelle assembly (GO:1902117) | 3.51012471 |
| 117 | pyrimidine-containing compound biosynthetic process (GO:0072528) | 3.50871163 |
| 118 | folic acid metabolic process (GO:0046655) | 3.50316806 |
| 119 | oxygen transport (GO:0015671) | 3.49733004 |
| 120 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.45205627 |
| 121 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.45146653 |
| 122 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.44788971 |
| 123 | alpha-beta T cell differentiation (GO:0046632) | 3.44494311 |
| 124 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.42755777 |
| 125 | regulation of growth of symbiont in host (GO:0044126) | 3.42755777 |
| 126 | negative regulation of growth of symbiont in host (GO:0044130) | 3.42755777 |
| 127 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.42755777 |
| 128 | regulation of T cell cytokine production (GO:0002724) | 3.41791417 |
| 129 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.40010184 |
| 130 | regulation of T cell migration (GO:2000404) | 3.39689593 |
| 131 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.39592162 |
| 132 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.39206615 |
| 133 | tRNA aminoacylation for protein translation (GO:0006418) | 3.37765730 |
| 134 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.36809863 |
| 135 | tRNA aminoacylation (GO:0043039) | 3.34857164 |
| 136 | amino acid activation (GO:0043038) | 3.34857164 |
| 137 | lung lobe morphogenesis (GO:0060463) | 3.34364651 |
| 138 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.31918421 |
| 139 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.31918421 |
| 140 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.29171379 |
| 141 | T cell costimulation (GO:0031295) | 3.28893991 |
| 142 | negative regulation of cell killing (GO:0031342) | 3.28236646 |
| 143 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.28236646 |
| 144 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 3.27831418 |
| 145 | dendritic cell differentiation (GO:0097028) | 3.26157926 |
| 146 | hormone catabolic process (GO:0042447) | 3.26079600 |
| 147 | regulation of interleukin-12 production (GO:0032655) | 3.25887481 |
| 148 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 3.25333752 |
| 149 | positive regulation of DNA replication (GO:0045740) | 3.24408918 |
| 150 | * regulation of isotype switching (GO:0045191) | 3.23599605 |
| 151 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.23524238 |
| 152 | lymphocyte costimulation (GO:0031294) | 3.23019120 |
| 153 | regulation of heat generation (GO:0031650) | 3.21172620 |
| 154 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.19676121 |
| 155 | embryonic placenta development (GO:0001892) | 3.17016316 |
| 156 | ER overload response (GO:0006983) | 3.13239549 |
| 157 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.03213958 |
| 158 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.03148064 |
| 159 | COPII vesicle coating (GO:0048208) | 3.01761418 |
| 160 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.00343070 |
| 161 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.97347796 |
| 162 | ribosomal small subunit assembly (GO:0000028) | 2.92418975 |
| 163 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.81764181 |
| 164 | rRNA processing (GO:0006364) | 2.81088630 |
| 165 | transcription from mitochondrial promoter (GO:0006390) | 2.80170692 |
| 166 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.77051480 |
| 167 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.72269859 |
| 168 | postsynaptic membrane organization (GO:0001941) | 2.70068393 |
| 169 | ribosome assembly (GO:0042255) | 2.65484244 |
| 170 | viral protein processing (GO:0019082) | 2.64112613 |
| 171 | rRNA metabolic process (GO:0016072) | 2.63672897 |
| 172 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.62070445 |
| 173 | protein export from nucleus (GO:0006611) | 2.61755969 |
| 174 | positive regulation of macrophage differentiation (GO:0045651) | 2.60612663 |
| 175 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.60373841 |
| 176 | natural killer cell differentiation (GO:0001779) | 2.60204632 |
| 177 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.58487348 |
| 178 | pyrimidine nucleoside metabolic process (GO:0006213) | 2.57603413 |
| 179 | negative regulation of acute inflammatory response (GO:0002674) | 2.56979991 |
| 180 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.54782682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.84400276 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.30750597 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.30692296 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.91183979 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.59995857 |
| 6 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 4.49005386 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.25996348 |
| 8 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.21193024 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.19459341 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 3.70140053 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.65812525 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.41159767 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.39821483 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.29877617 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 3.21743199 |
| 16 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.18773420 |
| 17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.02685104 |
| 18 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.92342201 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.91712583 |
| 20 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.84712425 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.79703267 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.66366995 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.61777357 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.61037769 |
| 25 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.56658699 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 2.54696099 |
| 27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.53732412 |
| 28 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.52701157 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.45246178 |
| 30 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.41100710 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 2.32268725 |
| 32 | * TAF15_26573619_Chip-Seq_HEK293_Human | 2.19945233 |
| 33 | EWS_26573619_Chip-Seq_HEK293_Human | 2.18104936 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.14127952 |
| 35 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.12513199 |
| 36 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.04657976 |
| 37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.03889693 |
| 38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.03833545 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 2.02240477 |
| 40 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.99760451 |
| 41 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.99591758 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.96810508 |
| 43 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.96683279 |
| 44 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.96466581 |
| 45 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.89775942 |
| 46 | MAF_26560356_Chip-Seq_TH2_Human | 1.87793413 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.87339006 |
| 48 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.82935557 |
| 49 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.82195781 |
| 50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.82073090 |
| 51 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.80746830 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.73490321 |
| 53 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.71276812 |
| 54 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.68110290 |
| 55 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.67835495 |
| 56 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.64020549 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.60339938 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.59137448 |
| 59 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.58995053 |
| 60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.52726512 |
| 61 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.50499670 |
| 62 | TP53_16413492_ChIP-PET_HCT116_Human | 1.47264972 |
| 63 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.45939008 |
| 64 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.45901751 |
| 65 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45277185 |
| 66 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.43757559 |
| 67 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43699141 |
| 68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42498866 |
| 69 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.41981106 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.38918869 |
| 71 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.37912379 |
| 72 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.37551268 |
| 73 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.37013554 |
| 74 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.34556656 |
| 75 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.32663949 |
| 76 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.31400848 |
| 77 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31399224 |
| 78 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.31151890 |
| 79 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.28474491 |
| 80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26191151 |
| 81 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25271958 |
| 82 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.23734137 |
| 83 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.23160359 |
| 84 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.22789032 |
| 85 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.22724706 |
| 86 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21001505 |
| 87 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20972907 |
| 88 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20238308 |
| 89 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.19548367 |
| 90 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.18950148 |
| 91 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16228479 |
| 92 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15481349 |
| 93 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.13813400 |
| 94 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.12081779 |
| 95 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.11205680 |
| 96 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.09866450 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09827053 |
| 98 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.09047111 |
| 99 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.08740460 |
| 100 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.08502145 |
| 101 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08409602 |
| 102 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08347370 |
| 103 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.06407929 |
| 104 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.06176699 |
| 105 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05576276 |
| 106 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05257593 |
| 107 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.04690490 |
| 108 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04579458 |
| 109 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.04269477 |
| 110 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.03556308 |
| 111 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.03322269 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01996555 |
| 113 | ERA_21632823_ChIP-Seq_H3396_Human | 1.01474817 |
| 114 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99919401 |
| 115 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.99883883 |
| 116 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.97811596 |
| 117 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.96459855 |
| 118 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.96372760 |
| 119 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.95322710 |
| 120 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94128511 |
| 121 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93908619 |
| 122 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.92664603 |
| 123 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.92664603 |
| 124 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91856272 |
| 125 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.90993497 |
| 126 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.90939439 |
| 127 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88853020 |
| 128 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.87512283 |
| 129 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.87327374 |
| 130 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86831714 |
| 131 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.86257103 |
| 132 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.85526649 |
| 133 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85187466 |
| 134 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84113922 |
| 135 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.82210708 |
| 136 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.81967290 |
| 137 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.80891566 |
| 138 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.80332313 |
| 139 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.80287321 |
| 140 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.79819356 |
| 141 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.77754046 |
| 142 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77745331 |
| 143 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.75868280 |
| 144 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.75325882 |
| 145 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74386029 |
| 146 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74346001 |
| 147 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.73597731 |
| 148 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.73234621 |
| 149 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.72278937 |
| 150 | ATF3_27146783_Chip-Seq_COLON_Human | 0.71188044 |
| 151 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.71079845 |
| 152 | SPI1_23127762_ChIP-Seq_K562_Human | 0.68436277 |
| 153 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.68057307 |
| 154 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.67778555 |
| 155 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.66090334 |
| 156 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.65297932 |
| 157 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64262527 |
| 158 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.64057001 |
| 159 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.63663264 |
| 160 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.62644091 |
| 161 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.62226301 |
| 162 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.62009835 |
| 163 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.61530290 |
| 164 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.61294027 |
| 165 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.61287716 |
| 166 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.60972610 |
| 167 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.60834075 |
| 168 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.59768193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.98594875 |
| 2 | MP0000685_abnormal_immune_system | 4.98752432 |
| 3 | MP0003763_abnormal_thymus_physiology | 4.40469353 |
| 4 | MP0003436_decreased_susceptibility_to | 4.38781128 |
| 5 | MP0003786_premature_aging | 3.90977288 |
| 6 | * MP0001835_abnormal_antigen_presentation | 3.87072085 |
| 7 | MP0006292_abnormal_olfactory_placode | 3.86529427 |
| 8 | MP0009333_abnormal_splenocyte_physiolog | 3.78711683 |
| 9 | MP0003303_peritoneal_inflammation | 3.44575705 |
| 10 | MP0003866_abnormal_defecation | 3.20902021 |
| 11 | MP0004147_increased_porphyrin_level | 3.04911828 |
| 12 | MP0004782_abnormal_surfactant_physiolog | 2.91088034 |
| 13 | MP0001790_abnormal_immune_system | 2.88212298 |
| 14 | MP0005387_immune_system_phenotype | 2.88212298 |
| 15 | MP0002736_abnormal_nociception_after | 2.84483100 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.84170970 |
| 17 | * MP0002405_respiratory_system_inflammati | 2.79983894 |
| 18 | MP0009785_altered_susceptibility_to | 2.71613661 |
| 19 | MP0001800_abnormal_humoral_immune | 2.68581259 |
| 20 | MP0003329_amyloid_beta_deposits | 2.65266641 |
| 21 | MP0002234_abnormal_pharynx_morphology | 2.54489977 |
| 22 | MP0005670_abnormal_white_adipose | 2.54209117 |
| 23 | * MP0000604_amyloidosis | 2.53917086 |
| 24 | MP0006082_CNS_inflammation | 2.45533574 |
| 25 | MP0003878_abnormal_ear_physiology | 2.33130559 |
| 26 | MP0005377_hearing/vestibular/ear_phenot | 2.33130559 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 2.31592479 |
| 28 | MP0002723_abnormal_immune_serum | 2.29882216 |
| 29 | MP0004510_myositis | 2.24758822 |
| 30 | MP0001873_stomach_inflammation | 2.21849601 |
| 31 | MP0005025_abnormal_response_to | 2.20338745 |
| 32 | MP0001958_emphysema | 2.19847014 |
| 33 | * MP0002398_abnormal_bone_marrow | 2.19010963 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 2.18772713 |
| 35 | MP0002166_altered_tumor_susceptibility | 2.17492479 |
| 36 | MP0008057_abnormal_DNA_replication | 2.13986212 |
| 37 | MP0010155_abnormal_intestine_physiology | 2.05543534 |
| 38 | MP0002420_abnormal_adaptive_immunity | 2.05472771 |
| 39 | * MP0003300_gastrointestinal_ulcer | 2.00973739 |
| 40 | MP0001819_abnormal_immune_cell | 2.00949188 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.99421473 |
| 42 | MP0009697_abnormal_copulation | 1.96795124 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.95144620 |
| 44 | MP0001881_abnormal_mammary_gland | 1.91107366 |
| 45 | MP0001968_abnormal_touch/_nociception | 1.87991694 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.85843304 |
| 47 | MP0004808_abnormal_hematopoietic_stem | 1.83206270 |
| 48 | * MP0000689_abnormal_spleen_morphology | 1.79764084 |
| 49 | MP0000716_abnormal_immune_system | 1.77313073 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.76992818 |
| 51 | MP0004885_abnormal_endolymph | 1.76834784 |
| 52 | MP0001501_abnormal_sleep_pattern | 1.67112760 |
| 53 | MP0002006_tumorigenesis | 1.67020130 |
| 54 | * MP0002722_abnormal_immune_system | 1.65087649 |
| 55 | MP0003718_maternal_effect | 1.57770240 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.54987686 |
| 57 | * MP0001845_abnormal_inflammatory_respons | 1.45868911 |
| 58 | MP0002938_white_spotting | 1.43101175 |
| 59 | * MP0002429_abnormal_blood_cell | 1.41619498 |
| 60 | MP0004133_heterotaxia | 1.38291208 |
| 61 | MP0004947_skin_inflammation | 1.37876617 |
| 62 | MP0002419_abnormal_innate_immunity | 1.34608243 |
| 63 | MP0004742_abnormal_vestibular_system | 1.32543649 |
| 64 | MP0010386_abnormal_urinary_bladder | 1.31204018 |
| 65 | MP0005423_abnormal_somatic_nervous | 1.30667437 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 1.30480449 |
| 67 | MP0002933_joint_inflammation | 1.26267010 |
| 68 | MP0003724_increased_susceptibility_to | 1.24718439 |
| 69 | MP0010030_abnormal_orbit_morphology | 1.20959848 |
| 70 | MP0008872_abnormal_physiological_respon | 1.18923835 |
| 71 | MP0000678_abnormal_parathyroid_gland | 1.18155247 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 1.18103878 |
| 73 | MP0003567_abnormal_fetal_cardiomyocyte | 1.16859993 |
| 74 | MP0008961_abnormal_basal_metabolism | 1.14495737 |
| 75 | MP0004145_abnormal_muscle_electrophysio | 1.12354105 |
| 76 | MP0003959_abnormal_lean_body | 1.09600345 |
| 77 | MP0001440_abnormal_grooming_behavior | 1.08418834 |
| 78 | MP0001984_abnormal_olfaction | 1.07763563 |
| 79 | MP0010307_abnormal_tumor_latency | 1.03134475 |
| 80 | MP0001661_extended_life_span | 1.02805409 |
| 81 | MP0009764_decreased_sensitivity_to | 1.02301801 |
| 82 | MP0004036_abnormal_muscle_relaxation | 1.01708371 |
| 83 | MP0000627_abnormal_mammary_gland | 1.01653252 |
| 84 | MP0002132_abnormal_respiratory_system | 1.00199045 |
| 85 | MP0005388_respiratory_system_phenotype | 0.98043567 |
| 86 | MP0002133_abnormal_respiratory_system | 0.98043567 |
| 87 | MP0001727_abnormal_embryo_implantation | 0.95237725 |
| 88 | MP0003879_abnormal_hair_cell | 0.93380086 |
| 89 | MP0003448_altered_tumor_morphology | 0.90733688 |
| 90 | MP0005166_decreased_susceptibility_to | 0.87524075 |
| 91 | MP0005165_increased_susceptibility_to | 0.86166889 |
| 92 | MP0000490_abnormal_crypts_of | 0.86106311 |
| 93 | * MP0001853_heart_inflammation | 0.85022402 |
| 94 | MP0005464_abnormal_platelet_physiology | 0.83456335 |
| 95 | MP0001293_anophthalmia | 0.82856308 |
| 96 | MP0001188_hyperpigmentation | 0.82466439 |
| 97 | MP0005636_abnormal_mineral_homeostasis | 0.81954515 |
| 98 | MP0008789_abnormal_olfactory_epithelium | 0.80729316 |
| 99 | MP0002019_abnormal_tumor_incidence | 0.79939419 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.79871798 |
| 101 | MP0005390_skeleton_phenotype | 0.78091194 |
| 102 | MP0009053_abnormal_anal_canal | 0.77986233 |
| 103 | MP0001663_abnormal_digestive_system | 0.77884061 |
| 104 | MP0003119_abnormal_digestive_system | 0.77642204 |
| 105 | MP0000049_abnormal_middle_ear | 0.77436627 |
| 106 | MP0004142_abnormal_muscle_tone | 0.77243096 |
| 107 | MP0002282_abnormal_trachea_morphology | 0.76039014 |
| 108 | MP0003795_abnormal_bone_structure | 0.73193868 |
| 109 | * MP0000609_abnormal_liver_physiology | 0.72312110 |
| 110 | MP0002877_abnormal_melanocyte_morpholog | 0.72024142 |
| 111 | MP0008469_abnormal_protein_level | 0.71632277 |
| 112 | MP0002249_abnormal_larynx_morphology | 0.70901058 |
| 113 | MP0003938_abnormal_ear_development | 0.69359392 |
| 114 | MP0001851_eye_inflammation | 0.68783732 |
| 115 | MP0005076_abnormal_cell_differentiation | 0.68075402 |
| 116 | MP0000467_abnormal_esophagus_morphology | 0.67674092 |
| 117 | MP0000858_altered_metastatic_potential | 0.66477828 |
| 118 | MP0008995_early_reproductive_senescence | 0.64759636 |
| 119 | MP0001919_abnormal_reproductive_system | 0.62802131 |
| 120 | MP0005395_other_phenotype | 0.61224503 |
| 121 | MP0004381_abnormal_hair_follicle | 0.60953814 |
| 122 | MP0003453_abnormal_keratinocyte_physiol | 0.60075865 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.58961105 |
| 124 | MP0002272_abnormal_nervous_system | 0.57755375 |
| 125 | MP0003646_muscle_fatigue | 0.56727607 |
| 126 | MP0003633_abnormal_nervous_system | 0.56557492 |
| 127 | MP0000747_muscle_weakness | 0.55808518 |
| 128 | MP0006072_abnormal_retinal_apoptosis | 0.54927960 |
| 129 | MP0001485_abnormal_pinna_reflex | 0.54505382 |
| 130 | MP0003693_abnormal_embryo_hatching | 0.53999831 |
| 131 | MP0001545_abnormal_hematopoietic_system | 0.52775358 |
| 132 | MP0005397_hematopoietic_system_phenotyp | 0.52775358 |
| 133 | MP0002135_abnormal_kidney_morphology | 0.52518278 |
| 134 | MP0002751_abnormal_autonomic_nervous | 0.52364099 |
| 135 | MP0009763_increased_sensitivity_to | 0.52047292 |
| 136 | * MP0000465_gastrointestinal_hemorrhage | 0.52021842 |
| 137 | MP0004957_abnormal_blastocyst_morpholog | 0.51737950 |
| 138 | MP0009278_abnormal_bone_marrow | 0.51364423 |
| 139 | MP0000598_abnormal_liver_morphology | 0.43637383 |
| 140 | MP0001348_abnormal_lacrimal_gland | 0.43457511 |
| 141 | MP0003936_abnormal_reproductive_system | 0.42133623 |
| 142 | MP0004197_abnormal_fetal_growth/weight/ | 0.41953653 |
| 143 | MP0000350_abnormal_cell_proliferation | 0.41051451 |
| 144 | MP0003077_abnormal_cell_cycle | 0.40841768 |
| 145 | MP0008569_lethality_at_weaning | 0.39065438 |
| 146 | MP0005647_abnormal_sex_gland | 0.38483587 |
| 147 | MP0005381_digestive/alimentary_phenotyp | 0.37900468 |
| 148 | MP0002136_abnormal_kidney_physiology | 0.35742538 |
| 149 | MP0001765_abnormal_ion_homeostasis | 0.33610390 |
| 150 | MP0002089_abnormal_postnatal_growth/wei | 0.32305550 |
| 151 | MP0005310_abnormal_salivary_gland | 0.29943288 |
| 152 | MP0002083_premature_death | 0.27257850 |
| 153 | MP0001216_abnormal_epidermal_layer | 0.27099591 |
| 154 | MP0002088_abnormal_embryonic_growth/wei | 0.26396578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgM level (HP:0003496) | 9.49768005 |
| 2 | Increased density of long bones (HP:0006392) | 8.06920486 |
| 3 | IgA deficiency (HP:0002720) | 7.33824377 |
| 4 | T lymphocytopenia (HP:0005403) | 6.35760210 |
| 5 | Abnormality of T cell number (HP:0011839) | 6.19012067 |
| 6 | Persistence of primary teeth (HP:0006335) | 5.99285335 |
| 7 | 3-Methylglutaconic aciduria (HP:0003535) | 5.97111245 |
| 8 | Abnormality of T cells (HP:0002843) | 5.79866462 |
| 9 | Microvesicular hepatic steatosis (HP:0001414) | 5.52961521 |
| 10 | Poor speech (HP:0002465) | 5.45916416 |
| 11 | Gastrointestinal infarctions (HP:0005244) | 5.36857943 |
| 12 | Abnormality of T cell physiology (HP:0011840) | 5.11535416 |
| 13 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 5.06638752 |
| 14 | IgG deficiency (HP:0004315) | 4.93164344 |
| 15 | Thrombocytosis (HP:0001894) | 4.88702628 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.44284961 |
| 17 | Bicuspid aortic valve (HP:0001647) | 4.11362396 |
| 18 | Fatigue (HP:0012378) | 4.08185116 |
| 19 | Acute lymphatic leukemia (HP:0006721) | 4.07782487 |
| 20 | Severe combined immunodeficiency (HP:0004430) | 4.01658598 |
| 21 | Amaurosis fugax (HP:0100576) | 3.95524328 |
| 22 | Congenital, generalized hypertrichosis (HP:0004540) | 3.88419143 |
| 23 | Chronic diarrhea (HP:0002028) | 3.87498792 |
| 24 | Bile duct proliferation (HP:0001408) | 3.80197332 |
| 25 | Abnormal biliary tract physiology (HP:0012439) | 3.80197332 |
| 26 | Myocardial infarction (HP:0001658) | 3.74252046 |
| 27 | Arterial thrombosis (HP:0004420) | 3.72463545 |
| 28 | Eczematoid dermatitis (HP:0000976) | 3.72234718 |
| 29 | Dyschromatopsia (HP:0007641) | 3.69836050 |
| 30 | Recurrent fungal infections (HP:0002841) | 3.62800631 |
| 31 | Sensorimotor neuropathy (HP:0007141) | 3.62372520 |
| 32 | Nasal polyposis (HP:0100582) | 3.59322737 |
| 33 | Neoplasm of the peripheral nervous system (HP:0100007) | 3.53823637 |
| 34 | Joint swelling (HP:0001386) | 3.50958303 |
| 35 | Panhypogammaglobulinemia (HP:0003139) | 3.47608954 |
| 36 | Hypergammaglobulinemia (HP:0010702) | 3.46136278 |
| 37 | Gingivitis (HP:0000230) | 3.45745679 |
| 38 | Combined immunodeficiency (HP:0005387) | 3.40350760 |
| 39 | Recurrent viral infections (HP:0004429) | 3.36035734 |
| 40 | Chest pain (HP:0100749) | 3.34610790 |
| 41 | Polycythemia (HP:0001901) | 3.33517320 |
| 42 | Broad face (HP:0000283) | 3.33440358 |
| 43 | Hepatitis (HP:0012115) | 3.24725399 |
| 44 | Testicular atrophy (HP:0000029) | 3.23775871 |
| 45 | Peritonitis (HP:0002586) | 3.17337267 |
| 46 | Abnormality of B cell number (HP:0010975) | 3.14026479 |
| 47 | B lymphocytopenia (HP:0010976) | 3.14026479 |
| 48 | Constricted visual fields (HP:0001133) | 3.09780671 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 3.08549166 |
| 50 | Abnormality of the peritoneum (HP:0002585) | 3.06791474 |
| 51 | Back pain (HP:0003418) | 3.03278038 |
| 52 | Abnormality of the nasal septum (HP:0000419) | 2.98300809 |
| 53 | Type 2 muscle fiber atrophy (HP:0003554) | 2.97737312 |
| 54 | Acute myeloid leukemia (HP:0004808) | 2.97717024 |
| 55 | Somatic mutation (HP:0001428) | 2.96552506 |
| 56 | Increased hepatocellular lipid droplets (HP:0006565) | 2.95746261 |
| 57 | Abnormality of the nasal mucosa (HP:0000433) | 2.94508293 |
| 58 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.93060351 |
| 59 | Oral leukoplakia (HP:0002745) | 2.88744929 |
| 60 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.76648010 |
| 61 | Cerebral hemorrhage (HP:0001342) | 2.70546509 |
| 62 | Insomnia (HP:0100785) | 2.70243015 |
| 63 | Chronic sinusitis (HP:0011109) | 2.67089936 |
| 64 | Spontaneous abortion (HP:0005268) | 2.66733786 |
| 65 | Exertional dyspnea (HP:0002875) | 2.66711671 |
| 66 | Hyperlipoproteinemia (HP:0010980) | 2.63357190 |
| 67 | Premature loss of primary teeth (HP:0006323) | 2.59140954 |
| 68 | Rib fusion (HP:0000902) | 2.57863368 |
| 69 | Diplopia (HP:0000651) | 2.57540584 |
| 70 | Abnormality of binocular vision (HP:0011514) | 2.57540584 |
| 71 | Hepatosplenomegaly (HP:0001433) | 2.57075603 |
| 72 | Gingival bleeding (HP:0000225) | 2.54483071 |
| 73 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.52637617 |
| 74 | Muscle fiber atrophy (HP:0100295) | 2.51987593 |
| 75 | Recurrent bronchitis (HP:0002837) | 2.50045486 |
| 76 | Peripheral hypomyelination (HP:0007182) | 2.48466429 |
| 77 | Delayed myelination (HP:0012448) | 2.48086292 |
| 78 | Esophageal varix (HP:0002040) | 2.46445575 |
| 79 | Abnormal ciliary motility (HP:0012262) | 2.45707402 |
| 80 | Hypoalphalipoproteinemia (HP:0003233) | 2.45534321 |
| 81 | Lipid accumulation in hepatocytes (HP:0006561) | 2.43199278 |
| 82 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.38308630 |
| 83 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.38308630 |
| 84 | Vacuolated lymphocytes (HP:0001922) | 2.36672599 |
| 85 | Aplastic anemia (HP:0001915) | 2.36279427 |
| 86 | Fatigable weakness (HP:0003473) | 2.32654735 |
| 87 | Abnormality of the neuromuscular junction (HP:0003398) | 2.32654735 |
| 88 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.31213182 |
| 89 | Horseshoe kidney (HP:0000085) | 2.28923560 |
| 90 | Nephronophthisis (HP:0000090) | 2.28274597 |
| 91 | Chorioretinal atrophy (HP:0000533) | 2.27170424 |
| 92 | Chronic otitis media (HP:0000389) | 2.24767295 |
| 93 | Agammaglobulinemia (HP:0004432) | 2.24514398 |
| 94 | Thrombophlebitis (HP:0004418) | 2.22000622 |
| 95 | Leukocytosis (HP:0001974) | 2.21093483 |
| 96 | Acute hepatic failure (HP:0006554) | 2.19738422 |
| 97 | Confusion (HP:0001289) | 2.18002435 |
| 98 | Basal cell carcinoma (HP:0002671) | 2.17973681 |
| 99 | Premature graying of hair (HP:0002216) | 2.17327407 |
| 100 | Elfin facies (HP:0004428) | 2.16768260 |
| 101 | Upper limb muscle weakness (HP:0003484) | 2.16002075 |
| 102 | Lymphoma (HP:0002665) | 2.15422736 |
| 103 | Malnutrition (HP:0004395) | 2.09389600 |
| 104 | Pancytopenia (HP:0001876) | 2.08045712 |
| 105 | Vertebral fusion (HP:0002948) | 2.07953721 |
| 106 | Thyroiditis (HP:0100646) | 2.03915396 |
| 107 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.03619564 |
| 108 | Hypoplasia of the pons (HP:0012110) | 2.03215318 |
| 109 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.02963498 |
| 110 | Septate vagina (HP:0001153) | 2.00559944 |
| 111 | Stomatitis (HP:0010280) | 13.7262726 |
| 112 | Pulmonary infiltrates (HP:0002113) | 1.99970667 |
| 113 | Increased intramyocellular lipid droplets (HP:0012240) | 1.90968168 |
| 114 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.90837345 |
| 115 | Alveolar cell carcinoma (HP:0006519) | 1.90669315 |
| 116 | Depressed nasal tip (HP:0000437) | 1.88710470 |
| 117 | Renal Fanconi syndrome (HP:0001994) | 1.86292994 |
| 118 | Vasculitis (HP:0002633) | 1.85631032 |
| 119 | Abnormality of the carotid arteries (HP:0005344) | 1.85439901 |
| 120 | Malignant hyperthermia (HP:0002047) | 1.83881361 |
| 121 | Nonprogressive disorder (HP:0003680) | 1.83637313 |
| 122 | Hyperphosphaturia (HP:0003109) | 1.83232415 |
| 123 | Pallor (HP:0000980) | 1.81201971 |
| 124 | Abnormal number of incisors (HP:0011064) | 1.80368226 |
| 125 | Increased muscle lipid content (HP:0009058) | 1.79769214 |
| 126 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.78921645 |
| 127 | Spastic paraparesis (HP:0002313) | 1.78321383 |
| 128 | Portal hypertension (HP:0001409) | 1.77548152 |
| 129 | IgM deficiency (HP:0002850) | 1.74458504 |
| 130 | Abnormality of the pons (HP:0007361) | 1.74024191 |
| 131 | Renovascular hypertension (HP:0100817) | 1.73243566 |
| 132 | Broad-based gait (HP:0002136) | 1.73064112 |
| 133 | Hyperacusis (HP:0010780) | 1.72264082 |
| 134 | Squamous cell carcinoma (HP:0002860) | 1.71231994 |
| 135 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.70987160 |
| 136 | Ectopic kidney (HP:0000086) | 1.70772499 |
| 137 | Overriding aorta (HP:0002623) | 1.70665341 |
| 138 | Abnormality of the prostate (HP:0008775) | 1.69648024 |
| 139 | Abnormality of primary teeth (HP:0006481) | 1.69597655 |
| 140 | Entropion (HP:0000621) | 1.69302024 |
| 141 | Submucous cleft hard palate (HP:0000176) | 1.69002987 |
| 142 | Abnormality of the anterior horn cell (HP:0006802) | 1.68746852 |
| 143 | Degeneration of anterior horn cells (HP:0002398) | 1.68746852 |
| 144 | Epistaxis (HP:0000421) | 1.67657971 |
| 145 | Bilateral microphthalmos (HP:0007633) | 1.67402968 |
| 146 | Spondylolisthesis (HP:0003302) | 1.67068002 |
| 147 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.66685657 |
| 148 | Eosinophilia (HP:0001880) | 1.66233278 |
| 149 | Encephalitis (HP:0002383) | 1.65890550 |
| 150 | Cutaneous melanoma (HP:0012056) | 1.65423187 |
| 151 | Abnormality of the frontal sinuses (HP:0002687) | 1.65275713 |
| 152 | Chromsome breakage (HP:0040012) | 1.65081956 |
| 153 | Colitis (HP:0002583) | 1.65025983 |
| 154 | Acrocyanosis (HP:0001063) | 1.63656814 |
| 155 | Lymphopenia (HP:0001888) | 1.62498192 |
| 156 | Dysmetric saccades (HP:0000641) | 1.62416470 |
| 157 | Abnormality of eosinophils (HP:0001879) | 1.62031899 |
| 158 | Abnormality of the hepatic vasculature (HP:0006707) | 1.61392398 |
| 159 | Gastrointestinal stroma tumor (HP:0100723) | 1.61005862 |
| 160 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.60803181 |
| 161 | Pulmonary embolism (HP:0002204) | 1.59890517 |
| 162 | Rhinitis (HP:0012384) | 1.58131606 |
| 163 | Recurrent cutaneous fungal infections (HP:0011370) | 1.57233630 |
| 164 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.57233630 |
| 165 | Scanning speech (HP:0002168) | 1.56660994 |
| 166 | Arthralgia (HP:0002829) | 1.55599685 |
| 167 | Mitral valve prolapse (HP:0001634) | 1.54482861 |
| 168 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.54467156 |
| 169 | Osteolytic defects of the hand bones (HP:0009699) | 1.54467156 |
| 170 | Oligodontia (HP:0000677) | 1.53246883 |
| 171 | Nausea (HP:0002018) | 1.52353541 |
| 172 | Poikiloderma (HP:0001029) | 1.51937670 |
| 173 | Urinary urgency (HP:0000012) | 1.50487778 |
| 174 | Neutropenia (HP:0001875) | 1.49256499 |
| 175 | Thoracolumbar scoliosis (HP:0002944) | 1.47338316 |
| 176 | Vertigo (HP:0002321) | 1.46965854 |
| 177 | 2-3 toe syndactyly (HP:0004691) | 1.46153792 |
| 178 | Ureteral stenosis (HP:0000071) | 1.42374070 |
| 179 | Porencephaly (HP:0002132) | 1.40734605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PAK4 | 7.32716124 |
| 2 | TXK | 6.95571507 |
| 3 | MAP4K1 | 6.21671136 |
| 4 | ZAP70 | 4.14380562 |
| 5 | JAK3 | 3.61277048 |
| 6 | MAP3K14 | 3.20243913 |
| 7 | TAOK1 | 3.13865624 |
| 8 | MAP3K11 | 2.90251200 |
| 9 | ITK | 2.84551689 |
| 10 | PIM2 | 2.77973219 |
| 11 | TAOK2 | 2.68467371 |
| 12 | NEK1 | 2.38688570 |
| 13 | ICK | 2.34751115 |
| 14 | CHUK | 2.28685440 |
| 15 | IKBKB | 2.23017056 |
| 16 | MAP2K3 | 2.16286055 |
| 17 | MAP3K3 | 2.03862697 |
| 18 | PRKD3 | 2.03471820 |
| 19 | ADRBK2 | 1.96457002 |
| 20 | SIK3 | 1.94857124 |
| 21 | NME1 | 1.94332689 |
| 22 | TEC | 1.80117982 |
| 23 | MAP3K7 | 1.79851616 |
| 24 | MST1R | 1.77720527 |
| 25 | ZAK | 1.70194802 |
| 26 | ATR | 1.60247852 |
| 27 | GRK1 | 1.57697123 |
| 28 | EEF2K | 1.57649697 |
| 29 | CSK | 1.41793057 |
| 30 | BUB1 | 1.38997508 |
| 31 | NME2 | 1.29233380 |
| 32 | ACVR1B | 1.28821841 |
| 33 | LCK | 1.27023418 |
| 34 | RPS6KA4 | 1.25614288 |
| 35 | TSSK6 | 1.25402061 |
| 36 | DYRK2 | 1.14411856 |
| 37 | PIM1 | 1.10360679 |
| 38 | RAF1 | 1.09912778 |
| 39 | NTRK2 | 1.09208349 |
| 40 | HCK | 1.07807968 |
| 41 | PAK3 | 1.06676073 |
| 42 | ALK | 1.06520039 |
| 43 | TRIB3 | 1.05999207 |
| 44 | IKBKE | 1.05126822 |
| 45 | SYK | 1.04461761 |
| 46 | BTK | 1.02573934 |
| 47 | RPS6KA6 | 1.01793570 |
| 48 | MAP3K13 | 1.00781212 |
| 49 | TBK1 | 0.99811758 |
| 50 | PLK1 | 0.96883896 |
| 51 | BMPR2 | 0.94114011 |
| 52 | PAK2 | 0.93290780 |
| 53 | RPS6KC1 | 0.92060484 |
| 54 | RPS6KL1 | 0.92060484 |
| 55 | PRKCH | 0.90660936 |
| 56 | FGFR4 | 0.87224430 |
| 57 | UHMK1 | 0.86060002 |
| 58 | FGFR1 | 0.85630883 |
| 59 | STK10 | 0.85370105 |
| 60 | CDK12 | 0.85330255 |
| 61 | TYK2 | 0.83584963 |
| 62 | SIK1 | 0.81640490 |
| 63 | JAK2 | 0.78373226 |
| 64 | MAP3K5 | 0.77481523 |
| 65 | RPS6KA5 | 0.76293153 |
| 66 | NEK2 | 0.75933170 |
| 67 | MAP3K8 | 0.74639805 |
| 68 | PRKCQ | 0.73438968 |
| 69 | MAP3K10 | 0.72029478 |
| 70 | EIF2AK3 | 0.67930093 |
| 71 | PKN2 | 0.67052361 |
| 72 | MAP3K1 | 0.65621898 |
| 73 | RPS6KA1 | 0.64274995 |
| 74 | PASK | 0.61921442 |
| 75 | FGFR3 | 0.61289023 |
| 76 | ROCK2 | 0.60682191 |
| 77 | LYN | 0.59596948 |
| 78 | NUAK1 | 0.59120051 |
| 79 | JAK1 | 0.59073734 |
| 80 | ERBB3 | 0.59057588 |
| 81 | ERBB4 | 0.55907731 |
| 82 | LRRK2 | 0.55790504 |
| 83 | MAP3K4 | 0.55596525 |
| 84 | STK4 | 0.55336090 |
| 85 | FES | 0.55243450 |
| 86 | TYRO3 | 0.53557705 |
| 87 | TESK1 | 0.52590013 |
| 88 | GSK3A | 0.51805126 |
| 89 | PDK2 | 0.50059769 |
| 90 | GSK3B | 0.49531926 |
| 91 | WNK3 | 0.49479394 |
| 92 | MST4 | 0.49077144 |
| 93 | EIF2AK2 | 0.46865451 |
| 94 | MAPK14 | 0.46628436 |
| 95 | EIF2AK1 | 0.44381577 |
| 96 | PHKG2 | 0.43700692 |
| 97 | PHKG1 | 0.43700692 |
| 98 | INSRR | 0.43665606 |
| 99 | PDGFRB | 0.43326884 |
| 100 | MELK | 0.43032261 |
| 101 | ATM | 0.42514525 |
| 102 | CDK7 | 0.41570063 |
| 103 | CHEK1 | 0.40882789 |
| 104 | SRPK1 | 0.39473960 |
| 105 | MAP2K6 | 0.38244627 |
| 106 | MAPK10 | 0.37881550 |
| 107 | MKNK2 | 0.35819464 |
| 108 | SMG1 | 0.35782777 |
| 109 | CSNK2A1 | 0.35584421 |
| 110 | IGF1R | 0.35082247 |
| 111 | OBSCN | 0.34774550 |
| 112 | INSR | 0.34292251 |
| 113 | CDK4 | 0.34289601 |
| 114 | PDK1 | 0.32692912 |
| 115 | NLK | 0.32692778 |
| 116 | TGFBR1 | 0.29597266 |
| 117 | RPS6KA3 | 0.29017483 |
| 118 | EGFR | 0.28772779 |
| 119 | MAPKAPK2 | 0.28484536 |
| 120 | SCYL2 | 0.27786637 |
| 121 | CDK9 | 0.27470175 |
| 122 | CSNK1A1L | 0.26761818 |
| 123 | CDK6 | 0.26604618 |
| 124 | CDK1 | 0.26536976 |
| 125 | BRD4 | 0.26240110 |
| 126 | PRKCE | 0.25026540 |
| 127 | ERN1 | 0.24790801 |
| 128 | PLK3 | 0.24446197 |
| 129 | EPHB1 | 0.24380020 |
| 130 | PRKD2 | 0.24048946 |
| 131 | ABL1 | 0.23879390 |
| 132 | PRKDC | 0.23873664 |
| 133 | BMPR1B | 0.23824563 |
| 134 | CSNK2A2 | 0.23707631 |
| 135 | FRK | 0.23127091 |
| 136 | MAPK3 | 0.22135687 |
| 137 | CSNK1E | 0.21926925 |
| 138 | MAPK13 | 0.21822691 |
| 139 | ERBB2 | 0.21280095 |
| 140 | MAP2K7 | 0.20441337 |
| 141 | WNK1 | 0.19957894 |
| 142 | RPS6KB2 | 0.19504362 |
| 143 | SGK1 | 0.19133578 |
| 144 | CSNK1D | 0.18428256 |
| 145 | PRKCB | 0.17999310 |
| 146 | IRAK4 | 0.17556367 |
| 147 | RPS6KB1 | 0.16019892 |
| 148 | MTOR | 0.15457368 |
| 149 | GRK6 | 0.15417593 |
| 150 | SIK2 | 0.15404608 |
| 151 | MAPK8 | 0.15159204 |
| 152 | EPHA3 | 0.14862822 |
| 153 | MKNK1 | 0.14263681 |
| 154 | PTK6 | 0.13941264 |
| 155 | KDR | 0.13183747 |
| 156 | AURKB | 0.12794268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 8.38651554 |
| 2 | * Allograft rejection_Homo sapiens_hsa05330 | 5.20121112 |
| 3 | Basal transcription factors_Homo sapiens_hsa03022 | 4.05326609 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.33999477 |
| 5 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.27300571 |
| 6 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.04765449 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.90457053 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.86236834 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.58419184 |
| 10 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 2.54429352 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.50513995 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.49591640 |
| 13 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.49384753 |
| 14 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.48184558 |
| 15 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 2.26470398 |
| 16 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.95466288 |
| 17 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.94959161 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.87056632 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.84687052 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.77984819 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.75472009 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.69521665 |
| 23 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.63698631 |
| 24 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60781378 |
| 25 | * Measles_Homo sapiens_hsa05162 | 1.53781237 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52994659 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.48630179 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.47046309 |
| 29 | Base excision repair_Homo sapiens_hsa03410 | 1.46846326 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.41553904 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.36719817 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.27517135 |
| 33 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.27442823 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24744177 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.22397842 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19997222 |
| 37 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.18175318 |
| 38 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.13807735 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.11100601 |
| 40 | Mineral absorption_Homo sapiens_hsa04978 | 1.10768503 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03447412 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.02378253 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93596454 |
| 44 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.92013426 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 0.91774152 |
| 46 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.91439897 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 0.90862329 |
| 48 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86613411 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85863624 |
| 50 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.85645425 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.83034314 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82457936 |
| 53 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81712222 |
| 54 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81480614 |
| 55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.80992585 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80420453 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.79731907 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77151873 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74163412 |
| 60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.73690469 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69727752 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.69263200 |
| 63 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67836754 |
| 64 | Nicotine addiction_Homo sapiens_hsa05033 | 0.66789202 |
| 65 | Influenza A_Homo sapiens_hsa05164 | 0.66210510 |
| 66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63349082 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63052955 |
| 68 | Tuberculosis_Homo sapiens_hsa05152 | 0.62399129 |
| 69 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61878880 |
| 70 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60052360 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55707880 |
| 72 | Shigellosis_Homo sapiens_hsa05131 | 0.55241126 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53115166 |
| 74 | RNA transport_Homo sapiens_hsa03013 | 0.51943404 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50513275 |
| 76 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50150907 |
| 77 | Spliceosome_Homo sapiens_hsa03040 | 0.48174561 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47752203 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.47031371 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46237761 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43604559 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.42317412 |
| 83 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42263775 |
| 84 | Ribosome_Homo sapiens_hsa03010 | 0.42193089 |
| 85 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.38961090 |
| 86 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35582205 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35565990 |
| 88 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.35033712 |
| 89 | Parkinsons disease_Homo sapiens_hsa05012 | 0.34310099 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33573175 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.32611106 |
| 92 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.30405027 |
| 93 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.27621287 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27255344 |
| 95 | Purine metabolism_Homo sapiens_hsa00230 | 0.26323019 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25833278 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.24894943 |
| 98 | Cocaine addiction_Homo sapiens_hsa05030 | 0.23312083 |
| 99 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.23075322 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21665236 |
| 101 | Olfactory transduction_Homo sapiens_hsa04740 | 0.19919789 |
| 102 | Alzheimers disease_Homo sapiens_hsa05010 | 0.19178373 |
| 103 | RNA polymerase_Homo sapiens_hsa03020 | 0.18869110 |
| 104 | Taste transduction_Homo sapiens_hsa04742 | 0.18033427 |
| 105 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.17561232 |
| 106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.16287492 |
| 107 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.15572226 |
| 108 | RNA degradation_Homo sapiens_hsa03018 | 0.14894282 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.13395697 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.13140215 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.12920675 |
| 112 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.12690840 |
| 113 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.12616887 |
| 114 | Retinol metabolism_Homo sapiens_hsa00830 | 0.12586212 |
| 115 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.12434625 |
| 116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.12302870 |
| 117 | Huntingtons disease_Homo sapiens_hsa05016 | 0.12228101 |
| 118 | Prostate cancer_Homo sapiens_hsa05215 | 0.10970681 |
| 119 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.10842212 |
| 120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.09782215 |
| 121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.07841118 |
| 122 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.07671210 |
| 123 | Phototransduction_Homo sapiens_hsa04744 | 0.06913561 |
| 124 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.06774347 |
| 125 | Peroxisome_Homo sapiens_hsa04146 | 0.04535175 |
| 126 | Platelet activation_Homo sapiens_hsa04611 | 0.03276787 |
| 127 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.03075599 |
| 128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.02513514 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02127728 |
| 130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.01643842 |
| 131 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.01447543 |
| 132 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.00621543 |
| 133 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.00525829 |
| 134 | Pathways in cancer_Homo sapiens_hsa05200 | -0.0599497 |
| 135 | Proteoglycans in cancer_Homo sapiens_hsa05205 | -0.0524539 |
| 136 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | -0.0494019 |
| 137 | Lysine degradation_Homo sapiens_hsa00310 | -0.0446963 |
| 138 | Calcium signaling pathway_Homo sapiens_hsa04020 | -0.0444617 |
| 139 | Metabolic pathways_Homo sapiens_hsa01100 | -0.0335963 |
| 140 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0304314 |
| 141 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | -0.0277495 |
| 142 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | -0.0232804 |
| 143 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0169087 |
| 144 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | -0.0149394 |
| 145 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0111766 |

